Davis Technology Series: Connecting Industry, Academia & Science
Wednesday, October 23, 2013 at 4:30 PM (PDT)
San Francisco, California
London, United Kingdom
Building New Med-Tech Companies:
Not as Hard/Easy as You Think...
Featuring Keynote Speaker
Brook Byers is a general partner at Kleiner, Perkins, Caufield & Byers and has been with the firm since 1977. Brook has been closely involved with more than 60 new technology-based ventures, many of which have become public companies. He formed the first life-sciences practice group in the venture capital profession in 1984 and led KPCB to become a premier venture capital firm in the medical, healthcare and biotechnology sectors. Brook is on the Board of Trustees of Stanford University, a board member of the University of California, San Francisco, Medical Foundation and the New Schools Foundation. Raised in Atlanta, Georgia, Brook graduated with a B.A. in Electrical Engineering from Georgia Tech and received an M.B.A. from Stanford University.
Brook Byers will describe lessons learned from a decade of helping scientists and entrepreneurs build medically focused companies based on molecular diagnostics, biotech and informatics breakthroughs. He will include the scientific, product development, team, regulatory, reimbursement, adoption, market and financial challenges that must be managed and overcome to be successful. A recently difficult funding environment is turning around, but previous time-tested strategies need to be refined for contemporary success.
Target audience: Established and budding scientists, engineers, physicians and business-oriented entrepreneurs.
Wednesday, October 23rd, 2013
4:30 p.m. - 5:00 p.m. Cocktails & Hors d'Oeuvres
5:00 p.m. - 6:00 p.m. Presentation
6:00 p.m. - 7:00 p.m. Informal Discussion & Refreshments
Courtyard Marriott, Orchid Room at UC Davis Medical Center
4422 Y Street Sacramento, CA 95817
For questions, please contact Anna Gutierrez at (916) 734-2350 or via email, firstname.lastname@example.org
Hosted by Richard Levenson, M.D.
Sponsored by: Department of Pathology & Laboratory Medicine &
UC Davis Venture Catalyst